• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Investigation of the bone mineral density in hemodialysis patients for different terms].

作者信息

Tao L, Xu H, Sun M, Ikeda T

机构信息

Xiangya Hospital, Hunan Medical University, Changsha 410011.

出版信息

Hunan Yi Ke Da Xue Xue Bao. 1999;24(2):177-8.

PMID:11938784
Abstract

The investigate the change of bone mineral density(BMD) in hemodialysis patients for different terms of hemodialysis, 50 patients were divided into three groups according to the duration of hemodialysis. Group I was < 5 years. Group II was 5-10 years, and Group III > 10 years. The BMD of the patients were assayed by using dual energy X-ray bone absorptiometer. Serum calcium, phosphorus, aluminium, and intact parathyroid hormone(iPTH) were detected at the same time. The mean BMD and serum iPTH were 0.624 +/- 0.180 g.cm-2 and 9.67 +/- 9.46 ng.cm-1 in Group I, 0.573 +/- 0.160 g.ml-2 and 10.16 +/- 28.05 ng.ml-1 in Group II, and 0.513 +/- 0.117 g.cm-2 and 10.75 +/- 24.94 ng.ml-1 in Group III, respectively. There was no statistical significance in BMD (P > 0.05) and iPTH(P > 0.05) among the above groups. The BMD of hemodialysis patients is not affected by different terms of hemodialysis.

摘要

相似文献

1
[Investigation of the bone mineral density in hemodialysis patients for different terms].
Hunan Yi Ke Da Xue Xue Bao. 1999;24(2):177-8.
2
[Clinical study of concerning factors of decreased bone mineral content in hemodialysis patients].[血液透析患者骨矿物质含量降低相关因素的临床研究]
Nihon Jinzo Gakkai Shi. 1991 Jun;33(6):587-96.
3
Body composition in hemodialysis patients--is it different from that of normal subjects?血液透析患者的身体成分——与正常受试者有差异吗?
Clin Nephrol. 2000 Apr;53(4):291-5.
4
Conjunctival and corneal calcification and bone metabolism in hemodialysis patients.血液透析患者的结膜和角膜钙化与骨代谢
Am J Kidney Dis. 2002 Feb;39(2):291-6. doi: 10.1053/ajkd.2002.30548.
5
[The relationship between bone mineral density and secondary hyperparathyroidism bone disease].骨密度与继发性甲状旁腺功能亢进性骨病之间的关系
Hunan Yi Ke Da Xue Xue Bao. 2000 Feb 28;25(1):77-9.
6
Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.静脉注射帕立骨化醇治疗血液透析儿童继发性甲状旁腺功能亢进症。
Am J Kidney Dis. 2007 Jun;49(6):814-23. doi: 10.1053/j.ajkd.2007.03.008.
7
Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.不同透析液的血液透析患者透析期间血清镁的变化及其与低血压发作的关系。
Hemodial Int. 2006 Oct;10 Suppl 2:S16-23. doi: 10.1111/j.1542-4758.2006.00120.x.
8
Elevation of intact parathyroid hormone level is a risk factor for low bone mineral density in pretransplant patients with liver diseases.在患有肝脏疾病的移植前患者中,完整甲状旁腺激素水平升高是骨矿物质密度低的一个风险因素。
Transplant Proc. 2007 Dec;39(10):3182-5. doi: 10.1016/j.transproceed.2007.06.093.
9
The effect of sexual hormone abnormalities on proximal femur bone mineral density in hemodialysis patients and the possible role of RANKL.性激素异常对血液透析患者股骨近端骨密度的影响及核因子κB受体活化因子配体(RANKL)的可能作用。
Hemodial Int. 2008 Jan;12(1):100-7. doi: 10.1111/j.1542-4758.2008.00249.x.
10
Should COPD patients be routinely evaluated for bone mineral density?慢性阻塞性肺疾病患者是否应常规评估骨密度?
J Bone Miner Metab. 2003;21(4):242-6. doi: 10.1007/s00774-002-0416-0.